Literature DB >> 9230908

The multiple roles of tumour stroma.

N Wernert1.   

Abstract

Since the work of Judah Folkman in the 1970s demonstrating the importance of vascularization on tumour growth the many roles played by tumour stroma have been demonstrated. Vascular endothelial growth factor/vascular permeability factor appears to be the main in vivo inducer of both stromal blood vessels and other components of the tumour stroma. Its action is probably mediated through its strong and long-lasting effect on microvascular permeability leading to fibrin extravasation and organisation ("tumours are wounds that do not heal"). During tumour invasion, stromal fibroblasts participate in the degradation of the extracellular matrix (ECM) by secreting matrix degrading proteases as well as their downstream-activators. Stroma derived factors such as scatter factor/hepatocyte growth factor as well as interactions between neoplastic cells and the ECM can play a role in both tumour cell migration and proliferation. The ECM may also act as a reservoir for growth factors. A novel transcription factor encoded by the c-ets 1 proto-oncogene is likely to be involved in the transcriptional regulation of both tumour vascularization and invasion. This contribution summarizes recent developments in the tumour stroma field.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230908     DOI: 10.1007/s004280050053

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  32 in total

1.  Tenascin immunoreactivity in the large bowel and the liver in patients with colorectal cancer.

Authors:  M V Gulubova; T Vlaykova
Journal:  Histochem J       Date:  2001-02

2.  Priming and potentiation of DNA damage response by fibronectin in human colon cancer cells and tumor-derived myofibroblasts.

Authors:  Jean Y J Wang; Christian Gespach; Olivier DE Wever; Joëlle Sobczak-Thépot; Anne-Sophie Vercoutter-Edouart; Jean-Claude Michalski; Radia Ouelaa-Benslama; Dwayne G Stupack; Marc Bracke; Shahin Emami
Journal:  Int J Oncol       Date:  2011-05-09       Impact factor: 5.650

3.  Tumour-stromal interactions in acid-mediated invasion: a mathematical model.

Authors:  Natasha K Martin; Eamonn A Gaffney; Robert A Gatenby; Philip K Maini
Journal:  J Theor Biol       Date:  2010-09-08       Impact factor: 2.691

4.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.

Authors:  L M Coussens; W W Raymond; G Bergers; M Laig-Webster; O Behrendtsen; Z Werb; G H Caughey; D Hanahan
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

5.  c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.

Authors:  M Tokunou; T Niki; K Eguchi; S Iba; H Tsuda; T Yamada; Y Matsuno; H Kondo; Y Saitoh; H Imamura; S Hirohashi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  'Malignant melanoma microecosystem': Immunohistopathological insights into the stromal cell phenotype.

Authors:  Pascale Quatresooz; Marie-Annick Reginster; Gérald E Piérard
Journal:  Exp Ther Med       Date:  2011-02-28       Impact factor: 2.447

7.  Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Authors:  Shanna A Arnold; Lee B Rivera; Andrew F Miller; Juliet G Carbon; Sean P Dineen; Yang Xie; Diego H Castrillon; E Helene Sage; Pauli Puolakkainen; Amy D Bradshaw; Rolf A Brekken
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

8.  WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors.

Authors:  D Pennica; T A Swanson; J W Welsh; M A Roy; D A Lawrence; J Lee; J Brush; L A Taneyhill; B Deuel; M Lew; C Watanabe; R L Cohen; M F Melhem; G G Finley; P Quirke; A D Goddard; K J Hillan; A L Gurney; D Botstein; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Involvement of large tenascin-C splice variants in breast cancer progression.

Authors:  Takatsugu Tsunoda; Hiroyasu Inada; Ilunga Kalembeyi; Kyoko Imanaka-Yoshida; Mirei Sakakibara; Ray Okada; Koji Katsuta; Teruyo Sakakura; Yuichi Majima; Toshimichi Yoshida
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.